Skip to main content
. 2020 Nov 5;31(5):2933–2943. doi: 10.1007/s00330-020-07387-3

Table 5.

Assessment of treatment response during and after adjuvant temozolomide (TMZ)

Assessment of treatment response No. of centres, n (%)
MacDonald criteria based 0 (0%)
RANO criteria based 7 (23%)
Standardised protocol not based on either MacDonald or RANO criteria 12 (39%)
No standardised protocol 12 (39%)